Keywords
Hyperprolactinemia
Adolescent
How to Cite
Abstract
Introduction: galactorrhea in adolescents is a rare clinical finding with variable etiology, ranging from physiological to pathological conditions. Its diagnostic approach must be systematic and individualized to determine the need for treatment.
Objectives: to describe a comprehensive clinical-diagnostic approach for the evaluation of adolescents with galactorrhea, highlighting the most frequent causes, recommended tests, and therapeutic strategies.
Methodology: a narrative review was conducted based on clinical guidelines and updated scientific literature on galactorrhea in the adolescent population, including national and international sources. We propose a stepped study algorithm guided by the clinical presentation.
Conclusions: in post-pubertal adolescents, pregnancy must be ruled out as the primary cause. Medications, especially antipsychotics, represent the most common secondary cause. Other frequent etiologies include hypothyroidism, polycystic ovary syndrome, and, less frequently, prolactinomas. In most cases, specific treatment is not necessary, except when there is persistent hyperprolactinemia, associated symptoms, or a treatable organic cause.
References
Sociedad Española de Ginecología y Obstetricia. Protocolos SEGO: Galactorrea. Actualizado en 2003. Prog Obstet Ginecol 2004; 47(1):59-64.
Saljoughian M. Atypical antipsychotics: safety and use in pediatric patients. US Pharm 2015; 40(5):52-5.
Speranza N. Cuando no hay más "remedio" que usar psicofármacos. Bol Farmacol 2019; 10(1). Disponible en: https://www.boletinfarmacologia.hc.edu.uy/images/2019/2019-1/4_psicofarmacos_1.pdf. (Consulta: 2 mayo 2025).
Uruguay. Institución Nacional de Derechos Humanos y Defensoría del Pueblo. Grupo de trabajo sobre medicalización y patologización de las infancias y adolescencias. Informe final. Montevideo: INDDHH; 2019. Disponible en: https://www.gub.uy/institucion-nacional-derechos-humanos-uruguay/sites/institucion-nacional-derechos-humanos-uruguay/files/documentos/publicaciones/Medicalizacio%CC%81n%20de%20la%20infancia_ctapa.pdf. (Consulta: 2 mayo 2025).
Mastroianni M, Ackermann C, Speranza N, Catenaccio V, Telechea H, Giachetto G, et al. Características del uso de psicofármacos en niños hospitalizados. Arch Pediatr Urug 2017; 88(3):132-41.
Barrios A, Barrios S, Behrens H, Bentos C, Di Catterina X, Maurente L, et al. Politerapia en niños y adolescentes hospitalizados en cuidados moderados en el Hospital Pediátrico del Centro Hospitalario Pereira Rossell (julio-setiembre 2019). Arch Pediatr Urug 2020; 91(4):207-24. doi: 10.31134/ap.91.4.3.
Rohn R. Galactorrhea in the adolescent. J Adolesc Health Care 1984; 5(1):37-49. doi: 10.1016/s0197-0070(84)80244-2.
Arias A, Alonso G, Pasqualini T. Prolactinoma en la adolescencia, un tumor frecuente: experiencia de un servicio de endocrinología pediátrica. Arch Argent Pediatr 2003; 101(2):122-6.
Allami C. Prolactina y función ovárica: diagnóstico y tratamiento. En: de la Parra I, Cortelezzi M, Lombardi E. Diagnóstico y terapéutica en endocrinología ginecológica y reproductiva. Buenos Aires: Journal, 2010:326-37.
Bruehlman R, Winters S, McKittrick C. Galactorrhea: rapid evidence review. Am Fam Physician 2022; 106(6):695-700.
Leung A, Pacaud D. Diagnosis and management of galactorrhea. Am Fam Physician 2004; 70(3):543-50.
Gosi S, Garla V. Galactorrhea. En: StatPearls. Treasure Island, FL: StatPearls, 2025. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK537115/. (Consulta: 2 mayo 2025).
Pol M, Monteagudo G, Santana F. Hiperprolactinemia y embarazo: aspectos clínicos. Rev Cuba Endocrinol 1999; 10(1):38-42.
Uruguay. Administración de Servicios de Salud del Estado. Estrategia de notificación y análisis de casos de niñas y adolescentes menores de 15 años en situación de embarazo: a tres años de su implementación en ASSE. Montevideo: ASSE; 2024. Disponible en: https://www.asse.com.uy/contenido/ASSE-presento-avances-en-implementacion-de-estrategia-de-notificacion-y-analisis-de-ninas-y-adolescentes-menores-de-15-anos-en-situacion-de-embarazo-14981. (Consulta: 2 mayo 2025).
Krøigaard S, Clemmensen L, Tarp S, Pagsberg A. A meta-analysis of antipsychotic-induced hypo- and hyperprolactinemia in children and adolescents. J Child Adolesc Psychopharmacol 2022; 32(7):374-89. doi: 10.1089/cap.2021.0140.
Sanfilippo J, Urizar R. Alteraciones de la mama. En: Kliegman R, Stanton B, St. Geme III J, Schor N, Behrman R. Nelson tratado de pediatría. 20 ed. Barcelona: Elsevier, 2016:2728-32.
Sirohi T, Singh H. Estimation of serum prolactin levels and determination of prevalence of hyperprolactinemia in newly diagnosed cases of subclinical hypothyroidism. J Family Med Prim Care 2018; 7(6):1279-82. doi: 10.4103/jfmpc.jfmpc_155_18.
Sharma N, Dutta D, Sharma L. Hyperprolactinemia in children with subclinical hypothyroidism. J Clin Res Pediatr Endocrinol 2017; 9(4):350-4. doi: 10.4274/jcrpe.4536.
Matalliotakis M, Koliarakis I, Matalliotaki C, Trivli A, Hatzidaki E. Clinical manifestations, evaluation and management of hyperprolactinemia in adolescent and young girls: a brief review. Acta Biomed 2019; 90(1):149-57. doi: 10.23750/abm.v90i1.8142.
Rogers A, Karavitaki N, Wass J. Diagnosis and management of prolactinomas and non-functioning pituitary adenomas. BMJ 2014; 349:g5390. doi: 10.1136/bmj.g5390.
Yang A, Cho S, Park H, Kim M, Kong D, Shin H, et al. Clinical, hormonal, and neuroradiological characteristics and therapeutic outcomes of prolactinomas in children and adolescents at a single center. Front Endocrinol (Lausanne) 2020; 11:527. doi: 10.3389/fendo.2020.00527.
Eren E, Törel A, Isgüven S, Çelebi E, Berberoglu M, Siklar Z, et al. Clinical and laboratory characteristics of hyperprolactinemia in children and adolescents: national survey. J Clin Res Pediatr Endocrinol 2019; 11(2):149-56. doi: 10.4274/jcrpe.galenos.2018.2018.0206.
Yang Y, Ke X, Duan L, Yang H, Gong F, Pan H, et al. Clinical characteristics and outcomes of prolactinomas in children and adolescents: a large retrospective cohort study. J Clin Endocrinol Metab 2024; 109(9):e1741-9. doi: 10.1210/clinem/dgad769.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Liliana Cedrés, Stephanie Viroga, Loreley García